This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Aditxt’s 8K filing here.
Aditxt Company Profile
Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.
Recommended Stories
- Five stocks we like better than Aditxt
- The Role Economic Reports Play in a Successful Investment Strategy
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Financial Services Stocks Investing
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- How Can Investors Benefit From After-Hours Trading
- MarketBeat Week in Review – 01/13 – 01/17
